Location History:
- Newark, CA (US) (2021 - 2024)
- Fremont, CA (US) (2022 - 2024)
- Thousand Oaks, CA (US) (2024)
Company Filing History:
7 out of 9 
2 out of 2 
2 out of 3 Years Active: 2021-2025
Title: Innovations of Katherine Harris
Introduction
Katherine Harris is a prominent inventor based in Newark, CA, known for her significant contributions to the field of biotechnology. With a total of 12 patents to her name, she has made remarkable advancements in the treatment of B-cell disorders.
Latest Patents
Her latest patents include the development of Anti-BCMA heavy chain-only antibodies, which are designed to treat B-cell disorders characterized by the expression of BCMA. These patents disclose methods for making such antibodies, as well as compositions, including pharmaceutical formulations, that utilize these antibodies. Additionally, she has developed heavy chain antibodies binding to CD19, known as Anti-CD19 heavy chain antibodies, which are also aimed at treating B-cell disorders characterized by CD19 expression.
Career Highlights
Katherine has worked with notable companies such as Teneobio, Inc. and Teneotwo, Inc., where she has played a crucial role in advancing innovative therapies. Her work has been instrumental in the development of new treatments that address critical health challenges.
Collaborations
Throughout her career, Katherine has collaborated with esteemed colleagues, including Nathan D Trinklein and Wim Van Schooten, contributing to a dynamic research environment that fosters innovation.
Conclusion
Katherine Harris stands out as a leading inventor in the biotechnology sector, with her groundbreaking patents and collaborations paving the way for future advancements in medical treatments. Her work continues to impact the field significantly.